Will Coronavirus herald a new era in vaccine innovation?

As this novel coronavirus continues to spread, and the number of people infected with COVID-19 keeps rising, the race is on to develop a vaccine. But the time it takes to carry out clinical trials, to ensure that a vaccine is both safe and effective, means this won’t happen overnight.

However, with at least 35 coronavirus vaccines now being developed, even compared to recent pandemics, we have new tools available that could help us reach that goal in record time.

Read more on the Gavi website here.

You May Also Like

Congratulating Linked Technical Facilitator, Cristiana Toscano, on Receiving the Oswaldo Cruz Medal of Merit

Please join us in congratulating Cristiana Toscano, Linked technical facilitator and Latin American-Caribbean (LAC) focal point, Professor of Epidemiology and Public Health at the Federal University of Goiás (UFG) in Brazil, and infectious disease doctor. Cristiana was recently honored by the federal government of Brazil with the Oswaldo Cruz Medal of Merit, along with 22 other … Read More

Linked Community News August 2024

This newsletter is available in English, Portuguese, Spanish, and Russian. We’re excited to bring you Linked updates from two recent learning engagements, a new practitioner perspective with Honduras, and the latest evidence from the global immunisation community to strengthen your immunisation programs. In July, Linked held two in-person learning engagements. Azerbaijan, Georgia, and Honduras, with … Read More

Join us for a Linked Webinar on One-dose HPV vaccination: Evidence, lessons learned and strategies, with experiences from Guyana and Estonia

Choosing or switching to a single dose HPV vaccination can simplify delivery and lower program costs. It can also help reduce the potential for supply shortages and alleviate delivery challenges such as those encountered during the COVID-19 pandemic. Whether countries are in the initial stages of introducing the HPV vaccine or considering a switch, they … Read More